About the Author
Dr. Cole has served on the journal editorial board from 1994-2001 as the Editor of "Trophoblast Disease Update". He has written more than 100 articles on hCG structure, physiology and immunoassay and on clinical applications of hCG or hCG-related molecules. He has a 1.17 FWCI in the Medicine category of SciVal where he has published throughout the various disciplines and maintains an average of 12.6 citations per article from 2009-2014. He has experience with international, single, and institutional collaboration. Awards and recognition for Dr. Cole include the Institute for Anticancer Research, Biannual Prize for best research; American Association for Clinical Chemistry, Most Outstanding Research Contributor to Clinical Chemistry Prize; Gynecology Oncology, Outstanding Speaker Award; and International Society for Study of Trophoblastic Disease, Gold Medal for most outstanding research. Dr. Butler attained his PhD from the University of London in 2001. He secured a Post Doctoral Fellowship at Yale University School of Medicine and became Assistant Professor at the University of New Mexico with the USA hCG Reference Service. Following lectureships at Queen Mary University of London and London Metropolitan University, he stood down as Reader (Associate Professor) from Middlesex University and UK higher education in June 2014. Dr Butler has published over 50 peer reviewed articles, reviews, letters and book chapters with the majority in the field of human chorionic gonadotropin (hCG) and in particular the role of hCG as a biomarker and treatment target in cancer and pregnancy.